This inventor holds 1 USPTO granted patent. Top assignee: Osteoneurogen Inc.. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Min Ju Ham: Innovator in Anti-Inflammatory Solutions
Introduction
Min Ju Ham is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of anti-inflammatory research. His innovative work has led to the development of a unique composition aimed at inhibiting inflammatory responses.
Latest Patents
Min Ju Ham holds 1 patent for an anti-inflammatory composition. This invention focuses on a compound that inhibits the interaction between CD14 and LPS. It effectively blocks the expression of CD14, TNFα, and IL-1β, which are critical factors in the inflammatory response. Additionally, the composition regulates the expression of important factors involved in inflammation, such as CCL2 (MCP-1), CCL7 (MCP-3), CXCL2, CHOP, and NOX1.
Career Highlights
Min Ju Ham is associated with Osteoneurogen Inc., where he continues to advance his research and development efforts. His work is pivotal in creating solutions that address inflammatory conditions, showcasing his commitment to improving health outcomes.
Collaborations
He collaborates with notable colleagues, including Byung Soo Youn and Han Soo Kim. Their combined expertise enhances the innovative potential of their projects.
Conclusion
Min Ju Ham's contributions to anti-inflammatory research exemplify the impact of innovation in healthcare. His patent reflects a significant advancement in understanding and managing inflammatory responses.